Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections

Authors

Sarah C. J. Jorgensen
Trang D. Trinh
Evan J. Zasowski, Touro University California
Abdalhamid M. Lagnf
Samuel P. Simon
Sahil Bhatia
Sarah M. Melvin
Molly E. Steed
Natalie A. Finch
Taylor Morrisette
Sandy J. Estrada
Joshua R. Rosenberg
Susan L. Davis
Michael J. Rybak

Publication Date

3-24-2020

DOI

10.1128/AAC.02291-19

ISSN

0066-4804

Recommended Citation

Jorgensen, S. C. J., Trinh, T. D., Zasowski, E. J., Lagnf, A. M., Simon, S. P., Bhatia, S., Melvin, S. M., Steed, M. E., Finch, N. A., Morrisette, T., Estrada, S. J., Rosenberg, J. R., Davis, S. L., & Rybak, M. J. (2020). Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrobial Agents and Chemotherapy, 64(4), e02291-19. https://doi.org/10.1128/AAC.02291-19

PubMed ID

31932379